Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of the Smartphone Application GERDCare
Recruiting
N/A
Interventional Study
GERD (Gastroesophageal Reflux Disease)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 380 (estimated)
- Sponsor
- Institute of Gastroenterology and Hepatology, Vietnam · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Adherence to GERD treatment, including medication, diet, and lifestyle, is essential for symptom control and complication prevention, yet adherence rates remain low due to various demographic and clinical factors. Digital therapeutics, particularly mobile health applications, have shown promising potential in supporting chronic disease management and improving patient outcomes.
The GERDCare mobil…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* ≥18 years old
* Presents with typical GERD symptoms (regurgitation, heartburn)
* Owns a smartphone and capable of using smartphone applications.
Exclusion Criteria:
* Acute GI conditions (upper GI bleeding, acute peptic ulcer…)
* GI malignancy (esophageal cancer, gastric can…
Contacts